Aug 06, 2020 / 12:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by and welcome to the BioCryst Second Quarter 2020 Earnings Call. (Operator Instructions)
Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. John Bluth of BioCryst. Thank you. Please go ahead, sir.
John D. Bluth - BioCryst Pharmaceuticals, Inc. - SVP of IR & Corporate Communications
Thank you, Tamia. Good morning, and welcome to BioCryst Second Quarter 2020 Corporate Update and Financial Results Conference Call. Today's press release and slides are available on our website. Participating with me today are CEO, Jon Stonehouse; CFO, Anthony Doyle; Chief Medical Officer, Dr. Bill Sheridan; Chief Business Officer, Megan Sniecinski; and Chief Commercial Officer, Charlie Gayer. Following our remarks, we will answer your questions.
Before we begin, please note that today's conference call will contain forward-looking statements, including those statements regarding future results,
Q2 2020 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot